University Hospital, Basel, Switzerland: Diabetes Insipidus trials

The registry lists 30 Diabetes Insipidus studies with University Hospital, Basel, Switzerland as lead sponsor. 7 are open to participants now and 0 have results posted.

Phase 2 3No phase 27(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Copeptin Measurement After Mannitol and Hypertonic Saline for the Diagnosis of Polyuria-polydipsia SyndromeRecruitingNCT07569861Not applicable
• Plasma Oxytocin Response to Oral Estrogens in Healthy Controls and AVP-DeficiencyRecruitingNCT07361263Not applicable
• Plasma Oxytocin Changes in Response to Music Modified by Sonic Augmentation TechnologyRecruitingNCT07276152Not applicable
• Protein Supplementation in Hyponatremia Due to the Syndrome of Inappropriate AntidiuresisRecruitingNCT06821802Not applicable
• Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy ControlsRecruitingNCT06789705Not applicable
• Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy ControlsRecruitingNCT06676774Phase 2
• Oxytocin Substitution Therapy in Patients With Central Diabetes InsipidusRecruitingNCT06036004Phase 2
• Mannitol-induced Release of Copeptin in Healthy Adults and Patients With Polyuria-Polydipsia Syndrome (MARS Study)CompletedNCT06542198Not applicable
• Plasma Copeptin in Response to Oral Urea in Healthy Adults and Patients With Polyuria-polydipsia SyndromeCompletedNCT05890690Not applicable
• Circulating Oxytocin Changes in Response to the Oxytocin System Stimulator MDMA in Patients With Diabetes Insipidus and Healthy ControlsCompletedNCT04648137Not applicable
• Copeptin After a Subcutaneous Stimulation With Glucagon in AdultsCompletedNCT04550520Not applicable
• The Influence of Water and Salt Intake on Copeptin Levels During Moderate Alcohol ConsumptionCompletedNCT03883503Not applicable
• Copeptin After an Oral Stimulation With Macimorelin in Healthy VolunteersCompletedNCT03844217Not applicable
• Use of Copeptin Measurement After Arginine Infusion for the Differential Diagnosis of Diabetes Insipidus - the CARGOx StudyCompletedNCT03572166Not applicable
• Copeptin in Outcome Prediction of an Acute Psychotic EpisodeCompletedNCT03235908
• Effects of GLP-1 Analogues on Fluid Intake in Patients With Primary Polydipsia (The GOLD-Study)CompletedNCT02770885Phase 2
• Perioperative Copeptin: Predictive Value and Risk Stratification in Patients Undergoing Major SurgeryCompletedNCT02687776
• Copeptin in Normal- to Hyperosmolar StatesCompletedNCT02647736Not applicable
• Copeptin for Prediction of Treatment Response in Children With Monosymptomatic Nocturnal Enuresis (MEN).CompletedNCT02621736
• The Circadian Rhythm of CopeptinCompletedNCT02604875
• Copeptin as a Stress Marker During a Written ExaminationCompletedNCT02051647
• Use of Copeptin in Diabetes InsipidusCompletedNCT01940614
• Copeptin After Arginine Infusion in Polyuria-Polydipsia SyndromeCompletedNCT01879137
• Copeptin During a Standardized Psychological Stress TestCompletedNCT01866137
• Copeptin Changes After Food IntakeCompletedNCT01772914
• Copeptin as a Diagnostic Marker in the Management of Neurosurgical Patients With Disturbance of Water HomeostasisCompletedNCT01465672
• Study of Copeptin as a Diagnostic Marker for Acute PancreatitisCompletedNCT01293318
• Copeptin for Risk Stratification in Non-traumatic Headache in the Emergency Setting - The CoHead StudyCompletedNCT01174901
• Copeptin in the Diagnosis and Differential Diagnosis of Diabetes Insipidus. The CoSIP-StudyCompletedNCT00757276
• The "COSMOS"-Study (Copeptin in Osmoregulation and Stress Assessment)CompletedNCT00390962